Drug intelligence / Profile preview

genistein + polyunsaturated fatty acids + vitamin K1 + vitamin D3

Development stage
Unknown
Lead developer
Royal DSM
Modality
Small Molecules
Administration
Oral
01

Overview

**genistein + polyunsaturated fatty acids + vitamin K1 + vitamin D3** is a combination dietary supplement studied primarily for bone health in postmenopausal women. The blend, referred to as geniVida bone blend (GBB), typically contains synthetic genistein (30 mg/day), vitamin D3 (800 IU/day), vitamin K1 (150 μg/day), and polyunsaturated fatty acids (1 g/day, EPA/DHA ratio ~2/1)[1][3][5]. - **Mechanism of action:** - **Genistein** is a phytoestrogen/isoflavone that acts as a selective estrogen receptor modulator and helps maintain bone mineral density by mild activation of estrogen receptors primarily in bone tissue. - **Polyunsaturated fatty acids (PUFA)**, mainly omega-3 fatty acids (EPA and DHA), are thought to have anti-inflammatory effects and may synergistically contribute to bone health, potentially via modulation of prostaglandin synthesis and inflammation pathways. - **Vitamin D3** enhances calcium absorption and regulates bone homeostasis. - **Vitamin K1** supports gamma-carboxylation of osteocalcin, a process necessary for bone mineralization[1][3][5]. - **Primary indication:** Prevention of osteoporosis and maintenance of bone mineral density in postmenopausal women; secondary indications under investigation may include general bone health and possible vascular/anti-inflammatory benefits. - **Developer:** DSM Nutritional Products[1][3].

Brand names
geniVida
Other names
GBBgeniVida bone blend
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)ESR2 (ERβ)GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on genistein + polyunsaturated fatty acids + vitamin K1 + vitamin D3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on genistein + polyunsaturated fatty acids + vitamin K1 + vitamin D3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call